Litcius/Paper detail

KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition

Yuanwang Pan, Han Han, Hai Hu, Hua Wang, Yueqiang Song, Hao Yuan, Xinyuan Tong, Ayushi S. Patel, Selim Mısırlıoğlu, Sittinon Tang, Hsin‐Yi Huang, Ke Geng, Ting Chen, Angeliki Karatza, Fiona Sherman, Kristen Labbe, Fan Yang, Alison Chafitz, Chengwei Peng, Chenchen Guo, André L. Moreira, Vamsidhar Velcheti, Sally C. M. Lau, Pengfei Sui, Haiquan Chen, J. Alan Diehl, Anil K. Rustgi, Adam J. Bass, John T. Poirier, Xiaoyang Zhang, Hongbin Ji, Zhang Hua, Kwok‐Kin Wong

2022Cancer Cell98 citationsDOIOpen Access PDF

Topics & Concepts

Cancer researchBiologyCarcinogenesisReceptor tyrosine kinaseSignal transductionCancerCell biologyGeneticsProtein Tyrosine PhosphatasesPI3K/AKT/mTOR signaling in cancerLung Cancer Treatments and Mutations
KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition | Litcius